SCHEMBL25535404

SCHEMBL25535404

c1ccc(-n2c3ccccc3c3cc(-c4ccc5c(c4)c4ccccc4n5-c4ccc5c(c4)nc4ccccn45)ccc32)cc1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 11/20 0.46
ALDH1A1 P00352 9/20 0.46
GAA P10253 9/20 0.46
GLA P06280 8/20 0.46
ATM Q13315 1/20 0.44
L3MBTL1 Q9Y468 1/20 0.44
HPGD P15428 6/20 0.44
NPC1 O15118 3/20 0.44
POLB P06746 2/20 0.44
RAB9A P51151 2/20 0.44
MEN1 O00255 1/20 0.44
MAPT P10636 1/20 0.44
KMT2A Q03164 1/20 0.44
SMN1; SMN2 Q16637 2/20 0.42
PTGER4 P35408 3/20 0.41
HSD17B10 Q99714 3/20 0.40
NPSR1 Q6W5P4 1/20 0.40
PDE10A Q9Y233 2/20 0.38
RAD51 Q06609 1/20 0.34
CASP1 P29466 2/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21622757 0.92 KDM4E (0.46) KDM4EALDH1A1GAAGLAATM
SCHEMBL23917137 0.92 KDM4E (0.46) KDM4EALDH1A1GAAGLAATM
SCHEMBL21622883 0.88 KDM4E (0.47) KDM4EALDH1A1GAAGLAATM
SCHEMBL21622976 0.85 KDM4E (0.51) KDM4EALDH1A1GAAGLAATM
SCHEMBL21622689 0.84 KDM4E (0.39) KDM4EALDH1A1GAAGLAATM
SCHEMBL23917075 0.83 KDM4E (0.45) KDM4EALDH1A1GAAGLAATM
SCHEMBL17658807 0.82 AKT2 (0.47) KDM4EALDH1A1GAAGLAATM
SCHEMBL23917069 0.82 KDM4E (0.41) KDM4EALDH1A1GAAGLAATM
SCHEMBL17658821 0.82 AKT2 (0.47) KDM4EALDH1A1GAAGLAATM
SCHEMBL17658820 0.82 AKT2 (0.47) KDM4EALDH1A1GAAGLAATM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230151032-A1 HETEROCYCLIC COMPOUND, LIGHT-EMITTING DEVICE INCLUDING HETEROCYCLIC COMPOUND, AND ELECTRONIC APPARATUS INCLUDING LIGHT-EMITTING DEVICE SAMSUNG DISPLAY CO., LTD. (KR) 2023-05-18 US disclosed
US-20230151032-A1 HETEROCYCLIC COMPOUND, LIGHT-EMITTING DEVICE INCLUDING HETEROCYCLIC COMPOUND, AND ELECTRONIC APPARATUS INCLUDING LIGHT-EMITTING DEVICE SAMSUNG DISPLAY CO., LTD. (KR) 2023-05-18 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230151032-A1 HETEROCYCLIC COMPOUND, LIGHT-EMITTING DEVICE INCLUDING HETEROCYCLIC COMPOUND, AND ELECTRONIC APPARATUS INCLUDING LIGHT-EMITTING DEVICE CRY1, CYP1A1, CYP2E1 KDM4E 3853/4885ALDH1A1 21/4885GAA 1589/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.